Literature DB >> 2174898

Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification.

Y S Chang1, Y S Tyan, S T Liu, M S Tsai, C C Pao.   

Abstract

The presence of Epstein-Barr virus (EBV) DNA sequences was examined by the polymerase chain reaction in 50 nasopharyngeal carcinoma (NPC) biopsy specimens and in two primary epithelial tumor cell cultures derived from patients with NPC. The detection limit was a single EBV genome equivalent by agarose gel electrophoresis followed by Southern blot analysis of the amplified products. EBV DNA sequences were detected in all 41 undifferentiated NPC cell specimens, in 2 of 4 moderately differentiated NPC cell specimens, and in 3 of 5 keratinized NPC cell specimens. Undifferentiated NPC cells were also found to contain higher copy numbers of EBV than cells of the other two types of NPC. Our data suggest that EBV replication may be closely associated with the differentiation of NPC tumor cells. The results also demonstrated a sensitive and specific method for the detection of EBV DNA sequences in NPC tumor cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174898      PMCID: PMC268195          DOI: 10.1128/jcm.28.11.2398-2402.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.

Authors:  W Henle; G Henle; H C Ho; P Burtin; Y Cachin; P Clifford; A de Schryver; G de-Thé; V Diehl; G Klein
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  Detection of a second widespread strain of Epstein-Barr virus.

Authors:  J W Sixbey; P Shirley; P J Chesney; D M Buntin; L Resnick
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

3.  Establishment and characterization of a tumor cell line from human nasopharyngeal carcinoma tissue.

Authors:  Y S Chang; S Y Lin; P F Lee; T Durff; H C Chung; M S Tsai
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

4.  Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma.

Authors:  G Henle; W Henle; G Klein; P Gunven; P Clifford; R H Morrow; J L Ziegler
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

5.  Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.

Authors:  T Lindahl; G Klein; B M Reedman; B Johansson; S Singh
Journal:  Int J Cancer       Date:  1974-06-15       Impact factor: 7.396

6.  Cloning and mapping of BamHi endonuclease fragments of DNA from the transforming B95-8 strain of Epstein-Barr virus.

Authors:  J Skare; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

7.  Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.

Authors:  G Klein; B C Giovanella; T Lindahl; P J Fialkow; S Singh; J S Stehlin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

8.  Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique.

Authors:  S Kaneko; S M Feinstone; R H Miller
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

9.  Southern analysis of genomic DNA with unique and degenerate oligonucleotide probes: a method for reducing probe degeneracy.

Authors:  P E Devlin; K L Ramachandran; R L Cate
Journal:  DNA       Date:  1988-09

10.  Replication of Epstein-Barr virus in human epithelial cells infected in vitro.

Authors:  J W Sixbey; E H Vesterinen; J G Nedrud; N Raab-Traub; L A Walton; J S Pagano
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

View more
  20 in total

1.  The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.

Authors:  C T Lin; C R Lin; G K Tan; W Chen; A N Dee; W Y Chan
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology.

Authors:  Pan Liu; Xiaodong Fang; Zizhen Feng; Yun-Miao Guo; Rou-Jun Peng; Tengfei Liu; Zhiyong Huang; Yue Feng; Xiaoqing Sun; Zhiqiang Xiong; Xiaosen Guo; Sha-Sha Pang; Bo Wang; Xiaojuan Lv; Fu-Tuo Feng; Da-Jiang Li; Li-Zhen Chen; Qi-Sheng Feng; Wen-Lin Huang; Mu-Sheng Zeng; Jin-Xin Bei; Yong Zhang; Yi-Xin Zeng
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma.

Authors:  Fei-Peng Zhao; Xiong Liu; Xiao-Mei Chen; Juan Lu; Bo-Long Yu; Wen-Dong Tian; L U Wang; Xia Xu; Hao-Ran Huang; Meng-Wen Zhang; Gang Li; Xiang-Ping Li
Journal:  Oncol Lett       Date:  2015-08-24       Impact factor: 2.967

4.  The validity of clinical feature profiles for cytomegaloviral anterior segment infection.

Authors:  Yih-Shiou Hwang; Chia-Rui Shen; Shirley H L Chang; Chi-Chun Lai; Chao-Lin Liu; Kuan-Jen Chen; Ken-Kuo Lin; Tun-Lu Chen; Ching-Hsi Hsiao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-21       Impact factor: 3.117

5.  Prevalence of Taiwan variant of Epstein-Barr virus in throat washings from patients with head and neck tumors in Taiwan.

Authors:  K C Jeng; C Y Hsu; M T Liu; T T Chung; S T Liu
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

6.  Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors.

Authors:  Y S Tyan; S T Liu; W R Ong; M L Chen; C H Shu; Y S Chang
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

7.  Expression of EBV encoded viral RNA 1, 2 and anti-inflammatory cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in Pakistan.

Authors:  Taimoor I Sheikh; Ishtiaq Qadri
Journal:  Diagn Pathol       Date:  2011-07-27       Impact factor: 2.644

8.  Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection.

Authors:  Wen-I Lee; Jainn-Jim Lin; Meng-Ying Hsieh; Syh-Jae Lin; Tang-Her Jaing; Shih-Hsiang Chen; Iou-Jih Hung; Chao-Ping Yang; Chin-Jung Chen; Yhu-Chering Huang; Shin-Pai Li; Jing-Long Huang
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

9.  Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.

Authors:  Imran Nawaz; Khalid Moumad; Debora Martorelli; Moulay Mustapha Ennaji; Xiaoying Zhou; Zhe Zhang; Riccardo Dolcetti; Meriem Khyatti; Ingemar Ernberg; Li-Fu Hu
Journal:  Clin Epigenetics       Date:  2015-08-22       Impact factor: 6.551

10.  Risk stratification based on change in plasma Epstein-Barr virus DNA load after treatment in nasopharyngeal carcinoma.

Authors:  Yuan Zhang; Wen-Fei Li; Yan-Ping Mao; Rui Guo; Ling-Long Tang; Hao Peng; Ying Sun; Qing Liu; Lei Chen; Jun Ma
Journal:  Oncotarget       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.